Serum from Mycobacterium bovis BCG-infected mice that had been challenged with lipopolysaccharide (LPS) exhibited a marked ability to induce gamma interferon (IFN-y) in cultures of spleen cells of normal mice in the presence of interleukin-2 (IL-2). The inducing activity became detectable in the circulatory system about 90 min after LPS challenge, disappeared at around 5 h, and was observable upon 640x dilution of the serum. Addition of monoclonal anti-IL-2 receptor antibody to the culture inhibited the induction by the serum. The activity induced high levels of IFN--y even in nylon wool-nonadherent cells, while concanavalin A failed to do so. Serum from uninfected mice challenged with LPS contained no such activity. The molecular weight of the active substance, estimated by gel filtration, was about 70,000. There were pronounced differences among mouse strains in the activities of the sera prepared, which paralleled the amounts of IFN-y produced in vivo. However, the levels of IFN--y produced in whole spleen cells and in nylon wool-nonadherent cells from mice of various strains were the same when stimulated with competent serum. These results indicate the existence of an unidentified factor that induces IFN--y in cooperation with IL-2 in macrophage-depleted splenocytes. They also suggest that IFN-,y production in vivo is not genetically controlled at the lymphocyte level but, rather, at the level of synthesis of the unknown factor.
the immune system by regulating the expression of surface antigens of mononuclear cells (3, 6, 23) or by regulating the antimicrobial or tumoricidal functions of macrophages or natural killer cells (17, 26) . Therefore, elucidation of the regulatory mechanism of IFN--y production would lead to a clearer understanding of the role of IFN-y in immune reac- tions. The cellular sources and mechanism of IFN--y secretion have hitherto been investigated by using either nonspecific stimuli, such as mitogens, or specific antigens (13) . Most of the results obtained have shown that T lymphocytes or natural killer cells produce IFN--y in the presence of accessory cells, and the participation of interleukin-2 (IL-2) has also been suggested (7, 11, 12, 16, 22) . However, details of the mechanism, for example, the mode of participation of macrophages or IL-2, still remain to be clarified.
Previously, we found that high titers of IFN--y were released into the circulatory system of bacteria-treated mice upon challenge with endotoxin (lipopolysaccharide [LPS] ) (20, 28) . LPS was also shown to induce IFN-y in lymphoid cells with the help of IL-2 (5, 14, 21) , and recently the involvement of IFN-y in LPS-induced inflammatory reactions was suggested (4, 8) . Because accessory cells were required for IFN--y induction by LPS and it seemed unlikely that LPS directly stimulated the producer cells, we were prompted to search for a second soluble factor participating in the induction mechanism of IFN--y production by LPS in vivo. Since high titers of IFN--y induced by LPS in bacteriatreated mice seemed to appear in the later phase (20, 28) , such a factor would probably exist in the circulation before the appearance of IFN--y.
On the other hand, evidence has accumulated which suggests that differences exist among various strains of mice in their capacities to produce IFN-y. The levels of IFN--y * Corresponding author. production induced by antigens or by mitogens in vivo (18) (19) (20) 25) or those induced in vitro (9, 10, 27) are influenced by murine genotypes, as are the levels of IFN-a/1 induction by LPS (2, 15) . However, since various cell populations are involved in IFN-y production, it is difficult to elucidate how the process is genetically controlled. It would thus be significant to investigate whether such control exists in the functions of accessory cells.
Here, we show that serum from Mycobacterium bovis BCG-infected mice challenged with LPS contains a soluble substance which is able to induce high levels of IFN-,y in spleen cell cultures depleted of plastic-and nylon wooladherent cells, in cooperation with human recombinant IL-2. We also show data suggesting that the synthesis of this factor is genetically controlled but that no strain variation is observable with regard to production of IFN--y by purified T lymphocytes or natural killer cells.
MATERIALS AND METHODS
Mice. Inbred C57BL/6, BALB/c, and A/J mice and outbred ICR mice, female, 8 to 12 weeks of age, were obtained from Shizuoka Laboratory Animal Center, Hamamatsu, Japan. CBA/JN mice and C3H/HeJ mice were obtained from Charles River Japan Inc., Atsugi, Japan, and from Clea Japan Inc., Osaka, Japan, respectively.
Reagents. Live lyophilized BCG (Japan BCG Manufacturing Co., Tokyo, Japan), LPS (Escherichia coli 0127:B8; Difco Laboratories, Detroit, Mich.), and concanavalin A (ConA; Pharmacia, Uppsala, Sweden) were commercially obtained. Recombinant human IL-2 was kindly donated by Takeda Chemical Industries, Osaka, Japan. Recombinant human IL-la (IL-la) and recombinant human tumor necrosis factor a (TNF-a) were kindly donated by Dainippon Pharmaceutical Co., Osaka, Japan.
Antibodies. Induction of IFN-y. Spleen cells from normal C57BL/6 mice were used for the assay of the IFN-y-inducing factor. Whole spleen or NWNA cells in 0.18 ml of RPMI 1640 medium as described above were placed in the wells of a 96-well flat-bottom microtest culture plate (Becton Dickinson). Inducers or variously diluted sera dissolved in 0.02 ml of PBS were added to the above cultures, which were then incubated for 24 h in an atmosphere containing 5% CO2 at 37°C, and the culture fluid was harvested for IFN assay. The IFN--y-inducing activity of the serum factor was tentatively expressed as the maximum dilution at which 160 U of IFN--y per ml was induced in the culture. IFN NWNA cells at the final concentration of 10% on microtest plates. Protein standards were applied to the same column, and the molecular weight of the IFN--y-inducing factor was estimated.
RESULTS
Profile of the appearance of the IFN-y-inducing factor in LPS-induced sera. The induction kinetics of circulating IFN--y and IFN--y-inducing factor in sera of BCG-infected mice after LPS challenge are shown in Fig. 1 . Serum samples were taken at various times after LPS challenge, appropriately diluted, and added to cultures of spleen cells from untreated mice, along with IL-2. Titration and characterization of IFN in the culture supernatant were carried out after 24 h of incubation. The IFN-y-inducing factor became de- tectable in the circulatory system about 90 min after LPS challenge, reached a peak after about 2 to 3 h, and disappeared at around 5 h. On the other hand, IFN--y appeared in the circulatory system at around 3 h after LPS challenge and reached a peak after about 4 to 5 h. Most of the BCGinfected mice challenged with LPS died by 7 h. No IFNy-inducing factor or IFN--y was observed in the sera of normal mice challenged with LPS or in those of BCGinfected mice challenged with PBS (data not shown).
Effect of IL-2 on IFN-,y induction by diluted serum. Appropriately diluted serum from a BCG-infected mouse challenged with LPS was added to the spleen cell culture and incubated for 24 h. Serum at a final dilution of between 1/40 and 1/160 effectively induced IFN-y production in these cells (Fig. 2) . At concentrations higher than a 1/20 dilution, the induction was suppressed, possibly because of an inhibitor(s). At concentrations lower than a 1/320 dilution, the induction by the serum alone was almost unobservable but was recovered effectively by the addition of IL-2. More than 2 U of IL-2 per ml was necessary for maximum induction. Thus, the decrease in IFN--y induction seemed to be due to the decrease in endogenous IL-2 when the serum was Induction of IFN--y production by LPS-induced serum factor. Sera were obtained from BCG-infected C57BL/6 mice 2 h after LPS inoculation, were diluted to various extents, and were added to the culture of spleen cells (10'/ml) from normal C57BL/6 mice in the presence or absence of IL-2 (2 U/ml). Control sera were obtained from normal C57BL/6 mice 2 h after LPS inoculation and were added to the culture in the presence of IL-2 (2 U/ml).
only a trace amount of IFN--y (in spleen cells), the participation of LPS remaining in the serum was negligible.
Effect of anti-IL-2 receptor antibody on IFN-y induction. Because IL-2 augmented IFN-y induction by the LPSinduced serum factor, and because the participation of IL-2 was believed to occur through the function of the IL-2 receptor, the effect of anti-IL-2 receptor antibody was examined by using whole spleen cells. Appropriately diluted anti-IL-2 receptor antibody was added to the culture of spleen cells (107 cells per ml) on microtest plates. After the plates were incubated for 1 h at 37°C, the LPS-induced serum factor from BCG-infected C57BL/6 mice 2 h after LPS inoculation with or without IL-2 (2 U/mi) was added at a final concentration of 1%. For cultures induced with the LPSinduced serum factor alone, the IFN--y titers were 560 ± 160 and 30 + 11 after treatment with PBS and anti-IL-2 receptor antibody, respectively; for cultures induced with the LPSinduced serum factor plus IL-2, the IFN--y titers were 2,240 ± 640 and 140 ± 40 after treatment with PBS and anti-IL-2 receptor antibody, respectively (all values, mean ± standard deviation for four experiments). Thus, the antibody effectively suppressed the induction when added 1 h before the LPS-induced serum factor, both in the presence and absence of exogenous IL-2. Furthermore, induction by ConA was also suppressed by the antibody (data not shown). Thus, the participation of IL-2 receptor in IFN--y induction in our system was strongly suggested.
Effect of depletion of adherent cells on IFN--y production. Since participation of macrophages in IFN-,y production has been pointed out by numerous investigators (24), we examined whether the unknown serum factor could substitute for macrophages. IL-2 or ConA alone induced a low level of IFN-y in cultures of whole spleen cells from untreated mice ( Table 1 ). The known LPS-elicited macrophage product IL-la or TNF-a, together with IL-2, was not able to induce IFN--y. The depletion of adherent cells completely eliminated IFN-y induction by ConA or by IL-2 alone. However, the induction by the LPS-induced serum factor in the presence of IL-2 in NWNA cells was somewhat augmented.
Perhaps the augmented induction in these cells was a result of the enrichment of the IFN--y-producing cells.
Estimation of the molecular weight of the serum factor. The IFN--y-inducing factor was fractionated with ammonium ConA (5 jig/ml) 160 <20
ConA (5 jig/ml) + IL-2 (2 U/ml) 160 <20 IL-la (1 to 100 U/ml) + IL-2 (2 U/ml) 40 <20 TNF-a (1 to 100 U/ml) + IL-2 (2 U/ml) 40 <20
LPS-induced serum factor (1%)b 320 640 LPS-induced serum factor (1%) + IL-2 640 2,560 (2 U/ml) a Adherent cells were removed by first adhering the spleen cells from normal C57BL/6 mice to a plastic plate for 1 h at 37°C and then applying the nonadherent cells to the nylon wool column as described in Materials and Methods.
b LPS-induced serum factor was obtained from BCG-infected C57BL/6 mice 2 h after LPS inoculation.
sulfate (55 to 75% saturation) and was applied to a column of Ultrogel AcA 44 (LKB Instruments) for the determination of molecular weight (Fig. 3) . Each fraction was examined for IFN-,y-inducing activity in NWNA cells in the presence or in the absence of IL-2. The activity exhibited a single and symmetric peak in the presence of IL-2, and the molecular weight of the fraction possessing the activity was estimated to be 70,000. Almost no activity was detected in the absence of added IL-2.
Variations among different strains of mice in the production of IFN-'y and IFN--y-inducing factor. Various strains of mice infected with BCG were challenged with LPS, and both circulating serum factor and IFN--y were assayed (Fig. 4) . the serum factor activity was compared in terms of the amount of IFN--y produced in the culture of NWNA cells from C57BL/6 mice when the serum was added at a lOOx dilution. Circulating IFN--y was assayed with sera taken from mice 4 h after LPS challenge. There were pronounced differences among various strains of inbred or outbred mice in the amounts of circulating IFN--y and IFN--y-inducing activity, and an obvious parallelism was observed between the two parameters. Strains producing large amounts of IFN--y, such as C57BL/6 or outbred ICR mice, were also high producers of the IFN--y-inducing factor. CBA/JN was a moderate producer, whereas BALB/c, C3H/HeJ, and A/J mice were low producers. Production of IFN-,y in NWNA cells from mice of various strains. To determine whether the strain differences in IFN-y production in vivo were ascribable to variations in the capacities of cells to produce the cytokine, NWNA cells from mice of various strains were examined by using the serum factor from high-producer mice, i.e., C57BL/6. No significant differences were observed among the various strains (Table 2) ; cells from low-producer mice, C3H/HeJ, BALB/c, and A/J, produced the same level of IFN--y as those from high-producer mice, C57BL/6 or ICR. Thus, genetic control of IFN--y production in vivo seemed to be exerted not on the producing cells themselves, but rather on the production of a stimulating factor like that described above.
DISCUSSION
Recently, it was demonstrated that IFN-y is involved in the LPS-induced inflammatory response (4, 8) , and previously, we found that LPS stimulated production of IFN--y and IFN-at/, in BCG-infected mice or in mice treated with heat-killed Propionibacterium acnes (20, 28) . Because these bacteria do not contain LPS, IFN--y induction by LPS did not appear to be due to an antigen-specific stimulus but rather to the ability of LPS to cause inflammation. Therefore, the existence of some unidentified factor which was expected to stimulate IFN--y production in vivo was anticipated. Recently, Wilson et al. indicated that IL-2-induced IFN--y synthesis requires the synergistic activity of IL-1 and possibly of one or more other monokines (29) . Antonelli et al. also claimed the existence of a macrophage-derived factor which differed from IL-1 and was able to induce IFN--y in resting T lymphocytes (1) .
In our present study, a factor stimulating IFN--y production in spleen cells was shown to be present in the serum of BCG-infected mice challenged with LPS ( Fig. 1 and 2 ). The appearance of the factor in the circulatory system preceded that of IFN--y, indicating that the factor is probably concerned with IFN--y production in vivo. As this serum also contained a strong inhibitor of IFN--y induction, the serum had to be diluted (Fig. 2) or fractionated (Fig. 3) .
Induction by the unknown factor was IL-2 dependent (Fig.  2) , because it was augmented upon IL-2 addition and, conversely, was inhibited in the presence of anti-IL-2 receptor antibody. Although IL-2 alone induced a low level of IFN--y in whole spleen cells, it failed to do so in NWNA cells (Table 1) , and the partially purified serum factor alone could not induce IFN--y in these cells (Fig. 3) . The relationship between IL-2 and this factor is very interesting but puzzling. The serum factor may increase the expression of surface IL-2 receptor, or it may be involved with the release of synthesized IFN--y from the cells stimulated by IL-2.
The cellular origin of the IFN--y-inducing factor was not investigated in the present study, but activated macrophages may produce it, since the culture supernatant of LPSstimulated adherent peritoneal exudate cells induced with P. acnes was able to induce IFN--y in NWNA cells in the presence of IL-2 (21) . From the beginning of investigations into IFN--y, a macrophage requirement for effective production of IFN--y has been indicated. However, details of the function of macrophages have not been elucidated. Contact between lymphocytes and macrophages may be necessary, or some soluble factor may substitute for macrophages. In the present study, such a macrophage requirement was overcome when IL-2 and the unknown factor were used for IFN--y induction (Table 1) . Induction by ConA was completely abolished by removal of splenic nylon wool-adherent cells, while induction by the serum factor plus IL-2 was somewhat augmented. Thus, production of IFN--y by resting lymphocytes is possibly induced by soluble factors, some of which are released from macrophages. Although neither IL-la nor TNF-a together with IL-2 was able to induce IFN--y production in NWNA cells, participation of such (29) . Such factors may not usually appear in the circulatory system but may be produced in local inflammatory sites. Preliminary experiments on the effect of the doses of both the partially purified IFN--y-inducing factor and IL-2 indicated that in the presence of enough IL-2, the amount of IFN--y induced by the factor increased linearly with the dose, whereas IFN--y production by IL-2 in the presence of enough factor increased sigmoidally. This may suggest that the IFN--y-inducing factor usually exhibits its functions in restricted environments.
Variations in the capacities of mouse strains to develop a cell-mediated immune response and also to produce IFN-y have been reported (18, 19, 25) . Investigations on such variations were carried out in vitro with mitogens and spleen cells (9, 10, 27) . However, the basic mechanisms of these differences among mouse strains in vivo have not been documented. In the present study, sera obtained from various strains of BCG-infected mice after LPS challenge exhibited marked differences in their capacities to induce IFN--y in NWNA cells prepared from mice of each strain (Fig. 4) . This variation agreed well with the quantity of IFN--y induced in the circulatory system, which appeared about 1 h after the serum factor. However, these NWNA cells elicited no significant difference among mouse strains (Table 2) . Cells from the mouse strain showing the lowest response (C3H/ HeJ) produced the same level of IFN-y as that produced in the cells from the highest-responding strain upon stimulation with IL-2 and the serum factor. This indicates the possibility that the genetic control of IFN-y production is not related to the control of the capacity of producing cells but to that of the function of accessory cells. Huygen and Palfliet (9) reported that CBA/Ca mice were low IFN-y producers in vivo but high IFN--y producers in vitro when stimulated with a specific antigen. Furthermore, they showed that in vitro IFN-y induction by ConA was also influenced by mouse genotype (10) . However, these studies were carried out with whole spleen cells, and the influence of accessory cells was not studied separately. Although we used different stimuli, our present results emphasize the influence of such accessory cells, which produce the IFN--y-inducing factor.
Molecular characterization of the IFN--y-inducing factor was not performed in the present study, but its roughly estimated molecular weight was 70,000, and the profile of its elution pattern on gel filtration was symmetric and not markedly spread (Fig. 3) . This suggests that the IFN-yinducing factor is a single molecular species. Its physiological roles, characterization, cellular source, and relationship to other cytokines, such as IL-1 or IL-2, will need to be clarified.
